These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27223)

  • 21. The propeptide of subtilisin BPN' as a temporary inhibitor and effect of an amino acid replacement on its inhibitory activity.
    Kojima S; Minagawa T; Miura K
    FEBS Lett; 1997 Jul; 411(1):128-32. PubMed ID: 9247157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of the ionization state of the active-site histidine in a subtilisin-(chloromethane inhibitor) derivative by 13C-NMR.
    O'Connell TP; Malthouse JP
    Biochem J; 1996 Jul; 317 ( Pt 1)(Pt 1):35-40. PubMed ID: 8694783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temperature-jump studies on benzeneboronic acid-serine protease interactions. Subtilisin and alpha-chymotrypsin.
    Nakatani H; Hanai K; Uehara Y; Hiromi K
    J Biochem; 1975 Apr; 77(4):905-8. PubMed ID: 238970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a novel peptide inhibitor of subtilisin BPN'.
    Ishida K; Shimizu M; Wakasugi A; Matsui Y; Nakamura A; Kojima S
    FEBS Open Bio; 2022 Nov; 12(11):2057-2064. PubMed ID: 36053920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. X-ray crystallographic study of boronic acid adducts with subtilisin BPN' (Novo). A model for the catalytic transition state.
    Matthews DA; Alden RA; Birktoft JJ; Freer ST; Kraut J
    J Biol Chem; 1975 Sep; 250(18):7120-6. PubMed ID: 1165237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stoichiometry of the interaction of human plasma alpha 1-proteinase inhibitor with subtilisin BPN'.
    Abe O; Kuromizu K
    J Biochem; 1989 Jan; 105(1):66-71. PubMed ID: 2661553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complex of subtilisin BPN' with Streptomyces subtilisin inhibitor. Complex formation concomitant with change in reducibility of disulfide bonds in the inhibitor.
    Komiyama T; Oomori A; Fukuyo K; Kanno H; Miwa M
    Int J Pept Protein Res; 1986 Oct; 28(4):325-33. PubMed ID: 3539839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the electrostatic perturbation of a catalytic site (Cys)-S-/(His)-Im+H ion-pair in one type of serine proteinase architecture by kinetic and computational studies on chemically mutated subtilisin variants.
    Plou FJ; Kowlessur D; Malthouse JP; Mellor GW; Hartshorn MJ; Pinitglang S; Patel H; Topham CM; Thomas EW; Verma C; Brocklehurst K
    J Mol Biol; 1996 Apr; 257(5):1088-111. PubMed ID: 8632470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of inhibitory activity of mutation at reaction site P4 of the Streptomyces subtilisin inhibitor, SSI.
    Kojima S; Kumagai I; Miura K
    Protein Eng; 1990 May; 3(6):527-30. PubMed ID: 2196560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of thiolsubtilisin with Streptomyces subtilisin inhibitor, SSI.
    Fujiwara K; Inouye K; Tonomura B; Murao S; Tsuru D
    J Biochem; 1977 Jul; 82(1):125-30. PubMed ID: 19450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large increases in general stability for subtilisin BPN' through incremental changes in the free energy of unfolding.
    Pantoliano MW; Whitlow M; Wood JF; Dodd SW; Hardman KD; Rollence ML; Bryan PN
    Biochemistry; 1989 Sep; 28(18):7205-13. PubMed ID: 2684274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resolution of independently titrating spectral components in the ultraviolet circular dichroism of subtilisin enzymes by matrix rank analysis.
    Brown MF; Schleich T
    Biochim Biophys Acta; 1977 Nov; 485(1):37-51. PubMed ID: 20969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cleavage points and reaction kinetics for the interaction of model peptides with subtilisin-BPN'.
    Blackburn W; Bilton RF; Crumption MJ; Law HD
    FEBS Lett; 1973 Aug; 34(2):333-6. PubMed ID: 4747847
    [No Abstract]   [Full Text] [Related]  

  • 34. Denaturation of subtilisin BPN' and its derivatives in aqueous guanidine hydrochloride solutions.
    Ikai A
    Biochim Biophys Acta; 1976 Aug; 445(1):182-93. PubMed ID: 8137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of soluble and active subtilisin and alpha-chymotrypsin in organic solvents via hydrophobic ion pairing.
    Meyer JD; Kendrick BS; Matsuura JE; Ruth JA; Bryan PN; Manning MC
    Int J Pept Protein Res; 1996 Mar; 47(3):177-81. PubMed ID: 8740967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering the independent folding of the subtilisin BPN' prodomain: analysis of two-state folding versus protein stability.
    Ruvinov S; Wang L; Ruan B; Almog O; Gilliland GL; Eisenstein E; Bryan PN
    Biochemistry; 1997 Aug; 36(34):10414-21. PubMed ID: 9265621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Furilisin: a variant of subtilisin BPN' engineered for cleaving tribasic substrates.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1996 Oct; 35(42):13579-85. PubMed ID: 8885837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the amino acid sequence of the serine protease of the fish pathogen Aeromonas salmonicida subsp. salmonicida with those of other subtilisin-type enzymes relative to their substrate-binding sites.
    Coleman G; Whitby PW
    J Gen Microbiol; 1993 Feb; 139(2):245-9. PubMed ID: 8436946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of subtilisin by boronic acids, potential analogs of tetrahedral reaction intermediates.
    Lindquist RN; Terry C
    Arch Biochem Biophys; 1974 Jan; 160(1):135-44. PubMed ID: 4364061
    [No Abstract]   [Full Text] [Related]  

  • 40. A study of subtilisin types Novo and Carlsberg by circular polarization of fluorescence.
    Schlessinger J; Roche RS; Steinberg IZ
    Biochemistry; 1975 Jan; 14(2):255-62. PubMed ID: 235273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.